ClinicalTrials.gg
RecruitingNCT07123532Updated Aug 14, 2025

PREVALENCE OF SCAPULAR DYSKINESIS

An observational study in Shoulder Pain, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 27 Years to 40 Years. Per ClinicalTrials.gov, last updated 2025-08-14.

Sponsored by Cairo University · Observational

From the registry’s dates

  • Primary completion was expected by Nov 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Aug 2025; still recruiting 1 year 3 months later.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
121
Ages
27 Years to 40 Years
Sex
All
01

Study summary

Objective:

This study will aim to determine the prevalence of scapular dyskinesis (SD) among Egyptian physical therapy practitioners and will explore associated epidemiological factors, including age, sex, BMI, shoulder and neck symptoms, and scapular stabilizer muscle strength.

Design:

A cross-sectional observational study will be conducted, including 121 licensed Egyptian physical therapists aged 27 to 40 years. Participants will be divided into three age-based groups.

Methods:

Each participant will undergo a clinical examination for SD using the Scapular Dyskinesis Test (SDT) and the Lateral Scapular Slide Test (LSST). Pain intensity will be assessed using the Visual Analog Scale (VAS), and musculoskeletal symptoms will be recorded using the Nordic Musculoskeletal Questionnaire (NMQ). Shoulder range of motion and the strength of scapular stabilizer muscles (serratus anterior, middle, and lower trapezius) will also be evaluated. Statistical analysis will include Chi-square tests and one-way ANOVA at a significance level of p \< 0.05.

Read the detailed description

This study will be a cross-sectional observational study designed to investigate the prevalence of scapular dyskinesis (SD) among physical therapy practitioners and to explore associated epidemiological factors. The study will be conducted between October 2024 and January 2025. Ethical approval will be obtained from the Research Ethics Committee of the Faculty of Physical Therapy, Cairo University (P.T.REC/012/005755).

Participants

Sample Size: The sample size will be calculated using SPSS for Windows, version 25, with 80% power at α = 0.05 level using a one-sample t-test. The generated sample size will be 121 physical therapy practitioners.

Selection Criteria:

Inclusion Criteria:

Licensed physical therapy practitioners actively working in clinical settings (Soliño et al., 2024).

Age between 27 and 40 years (Jeong \& Kim, 2023).

Minimum of one year of clinical experience or exposure to physical activity (Jeong \& Kim, 2023).

No current shoulder pain or symptoms at the time of assessment (Soliño et al., 2024).

Willingness to participate and provide informed consent.

Exclusion Criteria:

Acute shoulder or neck injury within the last month (Jeong \& Kim, 2023).

History of upper body orthopedic surgery (Jeong \& Kim, 2023).

Known neurological or musculoskeletal disorders affecting shoulder mechanics (Burn et al., 2016).

Participation in overhead or collision sports with high scapular loading (Burn et al., 2016).

Inability to complete assessment procedures due to physical limitations (Soliño et al., 2024).

Subgroups: Participants will be divided into three age-based groups:

Group A: 27-31 years

Group B: Above 31-36 years

Group C: Above 36-40 years

Instrumentation

Body Mass Index (BMI): Weight and height will be measured using calibrated scales, and BMI will be calculated as body mass (kg) / height² (m²). A cutoff of ≥30 kg/m² will be considered obese (Romero et al., 2008).

Scapular Dyskinesis Test (SDT): Will be used to visually assess scapular movement patterns during repeated shoulder flexion and abduction with light weights (Plummer et al., 2017).

Lateral Scapular Slide Test (LSST): Will assess scapular position by measuring the distance from the scapula's inferior angle to the nearest spinous process in different arm positions. A side-to-side difference >1.5 cm will indicate asymmetry (Curtis et al., 2006).

Digital Goniometer: Will be used to assess shoulder range of motion (ROM) with alignment to anatomical landmarks (Correll et al., 2018; Norkin \& White, 2016).

Visual Analog Scale (VAS): Will be used to measure pain intensity on a 10 cm line from 0 (no pain) to 10 (worst pain) (Begum et al., 2019).

Nordic Musculoskeletal Questionnaire (NMQ): An Arabic-adapted version will be used to assess musculoskeletal symptoms in specific body regions (Aldhabi et al., 2024).

Manual Muscle Testing (MMT): Strength testing of middle trapezius, lower trapezius, and serratus anterior will be conducted using the Oxford scale (Vijian et al., 2023).

Assessment Procedures

Personal Data: Name, age, sex, weight, and height will be recorded. Informed consent will be obtained from all participants.

BMI Calculation: Weight and height will be measured, and BMI will be computed using the standard formula (Abrantes et al., 2002).

Pain Assessment (VAS): Participants will mark their pain level on a 10 cm visual analog scale.

SDT: Participants will perform repeated shoulder flexion and abduction; abnormal scapular motion will be recorded as "yes" and normal as "no" (Jayasinghe, 2018).

LSST: Bilateral measurements will be taken in different arm positions; >1.5 cm difference will be considered abnormal (Jayasinghe, 2018).

Shoulder ROM Measurement: A digital goniometer will be used; the joint will be positioned and stabilized before measurement (Norkin \& White, 2016).

NMQ Administration: A self-administered questionnaire will address demographic, biomechanical, psychological, and environmental factors (Smith et al., 2006).

MMT: Strength of scapular stabilizers will be graded on the Oxford scale; only grade 5 will be included in analysis to avoid confounding.

Glenohumeral Joint Assessment: Passive ROM will be evaluated for pain response and end-feel categorization (Norkin \& White, 2016).

Statistical Analysis Data will be expressed as mean ± SD. The Shapiro-Wilk test will be used for normality testing. ANOVA will be applied to compare characteristics among the three subgroups, and the Chi-square test will be used to compare categorical variables. Statistical analysis will be performed using SPSS version 20 (SPSS Inc., Chicago, IL, USA), with significance set at p ≤ 0.05.

02

Conditions studied

  • Shoulder Pain

Keywords

  • Muscle Weakness
  • Scapular Dyskinesis
03

In context

Shoulder Pain

735 studies on the registry are indexed under Shoulder Pain; 167 are open to participants now.

This study's planned enrollment of 121 is above the median of 84 across 135 observational studies indexed under Shoulder Pain.

Browse Shoulder Pain studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
27 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

This cross-sectional observational study will investigate the prevalence of scapular dyskinesis (SD) among licensed physical therapy practitioners in Egypt and will explore associated epidemiological factors. The study will be conducted between October 2024 and January 2025 after obtaining ethical approval from the Research Ethics Committee, Faculty of Physical Therapy, Cairo University (P.T.REC/012/005755).

A total of 121 participants will be recruited based on a sample size calculation with 80% power at α = 0.05 (one-sample t-test). Eligible participants will be aged 27-40 years, actively working in clinical settings, with at least one year of clinical experience or exposure to physical activity, and free from current shoulder symptoms. Exclusion criteria will include recent acute shoulder/neck injury, history of upper body orthopedic surgery, neurological or musculoskeletal disorders affecting shoulder mechanics, high scapular-loading sports participation, and inability to complete

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Licensed physical therapy practitioners actively working in clinical settings (Soliño et al., 2024).

Age between 27 and 40 years (Jeong \& Kim, 2023).

Minimum of one year of clinical experience or exposure to physical activity (Jeong \& Kim, 2023).

No current shoulder pain or symptoms at the time of assessment (Soliño et al., 2024).

Willingness to participate and provide .

Exclusion criteria

Exclusion Criteria:

Acute shoulder or neck injury within the last month (Jeong \& Kim, 2023).

History of upper body orthopedic surgery (Jeong \& Kim, 2023).

Known neurological or musculoskeletal disorders affecting shoulder mechanics (Burn et al., 2016).

Participation in overhead or collision sports with high scapular loading (Burn et al., 2016).

Inability to complete assessment procedures due to physical limitations (Soliño et al., 2024).

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
121 participants (estimated)
Patient registry
No

Groups and cohorts

  • o Group A:

    27-31 years

  • o Group B:

    Above 31-36 years

  • o Group C:

    Above 36-40 years

06

What researchers measure

Primary outcomes

  1. Prevalence of Scapular Dyskinesis

    Determined by the proportion of participants diagnosed with abnormal scapular movement patterns using the Scapular Dyskinesis Test (SDT) and Lateral Scapular Slide Test (LSST). Measurement Method: SDT: Observation of scapular motion during repeated shoulder flexion and abduction with light weights. Abnormal motion recorded as "Yes," normal as "No." LSST: Measurement of distance from scapular inferior angle to the nearest spinous process in different arm positions; \>1.5 cm side-to-side difference indicates dyskinesis.

    Time frame: At baseline (single assessment session).

Secondary outcomes

  1. Shoulder Range of Motion (ROM)

    Measurement of active and passive ROM of the shoulder joint in degrees. Measurement Method: Digital goniometer aligned with anatomical landmarks (Norkin \& White, 2016).

    Time frame: At baseline.

  2. Scapular Stabilizer Muscle Strength

    Strength of the serratus anterior, middle trapezius, and lower trapezius. Measurement Method: Manual Muscle Testing (MMT) using Oxford scale; grade 5 only included in statistical analysis.

    Time frame: At baseline.

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07123532
Lead sponsor
Cairo University
Responsible party
Reda Abd Elaziz Ibrahim Abdo (general preactitioner, Cairo University) — Principal investigator
First posted
Aug 14, 2025
Start date
Aug 1, 2025
Primary completion
Nov 28, 2025 (estimated)
Completion
Dec 15, 2025 (estimated)
Last update
Aug 14, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion